Crossmark Global Holdings Inc. Has $19.12 Million Holdings in Procter & Gamble Co (NYSE:PG)

Crossmark Global Holdings Inc. reduced its holdings in Procter & Gamble Co (NYSE:PG) by 15.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 153,105 shares of the company’s stock after selling 27,749 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Procter & Gamble were worth $19,123,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Belmont Capital LLC acquired a new position in Procter & Gamble during the 4th quarter worth $34,000. Selective Wealth Management Inc. acquired a new position in Procter & Gamble during the 3rd quarter worth $35,000. Wealthcare Capital Management LLC lifted its holdings in Procter & Gamble by 126.0% during the 4th quarter. Wealthcare Capital Management LLC now owns 339 shares of the company’s stock worth $42,000 after buying an additional 189 shares in the last quarter. Pacifica Partners Inc. acquired a new position in Procter & Gamble during the 4th quarter worth $44,000. Finally, Lighthouse Financial Advisors Inc. acquired a new position in Procter & Gamble during the 4th quarter worth $44,000. 63.36% of the stock is currently owned by institutional investors and hedge funds.

PG stock opened at $126.14 on Friday. The business’s fifty day moving average is $125.01 and its 200-day moving average is $122.16. The company has a quick ratio of 0.44, a current ratio of 0.63 and a debt-to-equity ratio of 0.42. The company has a market cap of $308.58 billion, a P/E ratio of 74.64, a price-to-earnings-growth ratio of 3.30 and a beta of 0.36. Procter & Gamble Co has a twelve month low of $97.75 and a twelve month high of $128.09.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Thursday, January 23rd. The company reported $1.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.37 by $0.05. Procter & Gamble had a return on equity of 27.14% and a net margin of 6.92%. The company had revenue of $18.24 billion for the quarter, compared to the consensus estimate of $18.37 billion. During the same quarter in the prior year, the business posted $1.25 EPS. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. Research analysts anticipate that Procter & Gamble Co will post 4.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a $0.7459 dividend. This represents a $2.98 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date is Thursday, January 23rd. Procter & Gamble’s dividend payout ratio is currently 65.93%.

In related news, CEO David S. Taylor sold 58,297 shares of the company’s stock in a transaction on Monday, January 27th. The shares were sold at an average price of $125.93, for a total value of $7,341,341.21. Following the completion of the sale, the chief executive officer now owns 284,069 shares in the company, valued at approximately $35,772,809.17. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Carolyn M. Tastad sold 37,385 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $126.28, for a total transaction of $4,720,977.80. Following the completion of the sale, the insider now owns 60,191 shares of the company’s stock, valued at approximately $7,600,919.48. The disclosure for this sale can be found here. In the last 90 days, insiders sold 100,411 shares of company stock valued at $12,652,757. 1.75% of the stock is owned by corporate insiders.

A number of research analysts have recently weighed in on the company. Morgan Stanley reissued a “buy” rating and issued a $134.00 price target on shares of Procter & Gamble in a research note on Friday, January 24th. Macquarie increased their price target on Procter & Gamble from $132.00 to $138.00 and gave the company an “outperform” rating in a research note on Wednesday, October 23rd. Goldman Sachs Group reissued a “buy” rating and issued a $136.00 price target on shares of Procter & Gamble in a research note on Wednesday, October 23rd. TheStreet raised Procter & Gamble from a “c+” rating to a “b+” rating in a research note on Tuesday, October 22nd. Finally, UBS Group increased their price target on Procter & Gamble from $122.00 to $126.00 and gave the company a “neutral” rating in a research note on Wednesday, October 23rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and eight have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $124.86.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Featured Article: Initial Coin Offering (ICO)

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.